SCPH: scPharmaceuticals Inc. Stock

by  •  • Comments Off on SCPH: scPharmaceuticals Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 168.13
Enterprise Value ($M) 127.75
Book Value ($M) 30.71
Book Value / Share 0.61
Price / Book 5.48
NCAV ($M) 28.97
NCAV / Share 0.58
Price / NCAV 5.80

Profitability (mra)
Return on Invested Capital (ROIC) -0.96
Return on Assets (ROA) -0.85
Return on Equity (ROE) -2.15

Liquidity (mrq)
Quick Ratio 6.89
Current Ratio 8.08

Balance Sheet (mrq) ($M)
Current Assets 123.33
Assets 125.07
Liabilities 94.36
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-31 13G/A Hirschman Orin
01-28 13G/A King Luther Capital Management Corp
11-14 13G/A Lytton Laurence W 5.90 61.35
11-14 13G/A Lundbeckfond Invest A/S 5.70 -10.05
08-15 13D/A Orbimed Advisors Llc 12.10 8.99
04-05 13G/A BlackRock, Inc. 4.99 -3.32
2024-02-14 13G/A Armistice Capital, Llc 0.00 -100.00
2024-02-14 13G/A 5AM Ventures IV, L.P. 3.30 -56.10
2024-02-12 13G Rubric Capital Management LP 9.76
2024-02-02 13G/A Cowen Financial Products LLC 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-12-31 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANS
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 144,525 377,095 38.33
2025-02-20 89,052 299,366 29.75
2025-02-19 80,165 327,540 24.47
2025-02-18 58,555 214,474 27.30

(click for more detail)

Similar Companies
RVMD – Revolution Medicines, Inc. RXRX – Recursion Pharmaceuticals, Inc.
SANA – Sana Biotechnology, Inc. SDGR – Schrödinger, Inc.
SLDB – Solid Biosciences Inc.


Financial data and stock pages provided by
Fintel.io